2893803-05-7
Chemical Structure
BLT2 probe 1
- CAS. Nr.: 2893803-05-7
- Formula:C50H45N3O11S
- Molecular Weight:895.97
IUPAC Name: 4'-(1-((3-carboxy-4-(6-hydroxy-3-oxo-3H-xanthen-9-yl)phenyl)amino)-14-oxo-15-phenyl-1-thioxo-5,8,11-trioxa-2,15-diazahexadecan-16-yl)-[1,1'-biphenyl]-2-carboxylic acid
InChIKey: MFWAXYHVXYZLSC-UHFFFAOYSA-N
SMILES: S=C(NC1=CC(C(O)=O)=C(C=C1)C2=C(C(OC3=C2C=CC(O)=C3)=C4)C=CC4=O)NCCOCCOCCOCCC(N(C5=CC=CC=C5)CC6=CC=C(C7=C(C(O)=O)C=CC=C7)C=C6)=O
Biological Activity: BLT2 probe 1 (compound 13) is a fluorescent probe based on the synthetic BLT2 agonist CAY10583. BLT2 is a promising target for diabetic wound healing and gastrointestinal lesions. BLT2 probe 1 is suitable to investigate the pharmacology of BLT2 receptor ligands in a variety of assay systems[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BLT2 probe 1 | BLT2 probe 1 (compound 13) is a fluorescent probe based on the synthetic BLT2 agonist CAY10583. BLT2 is a promising target for diabetic wound healing and gastrointestinal lesions. BLT2 probe 1 is suitable to investigate the pharmacology of BLT2 receptor ligands in a variety of assay systems. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
